SecBot SecBot
SECBOTREPLAY Home › Report › PFE

PFE · Pfizer announced that CFO Dave Denton will step down effective August…

PFIZER INC · 8-K filed Jun 18, 2026 at 07:07 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 18, 2026 at 07:07 ET

Pfizer announced that CFO Dave Denton will step down effective August 15, 2026 to pursue a consumer goods opportunity, with Senior VP Cecile Guegan appointed as Interim CFO effective August 16. The company explicitly states the departure is unrelated to financial or operating results. A comprehensive internal and external search for a permanent CFO is underway.

  • CFO Dave Denton notified Pfizer on June 16, 2026 of his departure effective August 15, 2026 for a professional opportunity outside the pharmaceutical industry in consumer goods
  • Cecile Guegan, SVP Finance, Global Biopharmaceutical Business, named Interim CFO effective August 16, 2026
  • Departure stated as not related to the company's financial or operating results or any disagreements with accounting/reporting policies
  • Pfizer will conduct a comprehensive internal and external search for a permanent CFO successor

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access